Ganzhou Hemay Pharmaceutical Co., Ltd

This study tested how the psoriasis drug Hemay005 behaves in people with mild or moderate kidney issues versus those with normal kidneys. 26 adults took a single dose, and researchers measured drug levels in the blood. The goal was to help doctors decide the right dose for patien…

This completed Phase 1 study involved 20 adults with psoriasis to see how Hemay005 tablets affect the way the body processes another drug (midazolam). Researchers also checked for heart rhythm changes and measured inflammation markers. The goal was to gather safety and interactio…